The global pharmaceutical CDMO market was valued at USD 150 billion in 2023 and grew at a CAGR of 7% from 2024 to 2033. The market is expected to reach USD 295.07 billion by 2033. The increasing research and development expenditure will drive the growth of the global pharmaceutical CDMO market.
A Pharmaceutical CDMO stands for pharmaceutical Contract Development and Manufacturing Organization (CDMO). It is a business that offers its services to pharmaceutical and biotechnology companies. It assists in drug development and manufacturing. It also offers commercial production capabilities. It assists in clinical trials and research as well. CDMO allow pharmaceutical and biotechnology companies to outsource redundant and time-consuming tasks, enabling them to focus on their core competencies. It facilitates resource optimization. CDMOs are cost effective, efficient and reliable. They have the necessary infrastructure and expertise to facilitate drug development and production. They offer flexibility, thereby accommodating the need and demands of consumers. they also assist in regulatory compliance. They are equipped to navigate the complex nature of regulatory guidelines making it easier for clients to facilitate research, development, and innovation without having to worry about investing time and resources into understanding regulatory framework.
Get an overview of this study by requesting a free sample
Globalization of pharmaceuticals – globalization has paved the way for companies to optimize their resources by outsourcing their manufacturing and other relevant services to economies that offer low production costs. globalization also allows companies and businesses to access the best of technology, processes, systems and expertise. It also enables collaboration and partnerships that further healthcare and medicine. CDMOs are means or vehicles through which this happens. They offer these services in an effective, efficient, reliable and cost-effective manner without compromising on quality or compliance. The growing support from governments also contribute to the market’s growth. therefore, the globalization of healthcare, medicine and pharmaceuticals will contribute to the market’s growth.
Confidentiality concerns – outsourcing drug development and processing, trial assistance or manufacturing involves certain risks. The biggest risk being IP theft. Companies spend years and millions in developing breakthrough technologies and drugs. Having complete control over their IP and its use ensures that they can reap the benefits of their research through monopoly. Outsourcing manufacturing or development increases the risk of misuse or IP theft. This could cause loss in millions for the parent company. the involvement of several parties further exacerbates the risks. There are costs associated with legally protecting these rights and addressing them legally in case they are breached. However, all of this is time-consuming and capital intensive. Therefore, the confidentiality concerns will hamper the market’s growth.
Technological advancements – Technological advancements facilitating improvement and enhancement in AI, AR, blockchain technology, IoT and big data contribute to better efficacy, safety, and efficiency. Integration of these technologies by CDMOs automates redundant processes, increases precision and accuracy, reduces waste and enhances quality. it also paves the way forward for greater innovation. Therefore, technological advancements further the capabilities of pharmaceutical CDMOs and contribute to the market’s growth.
The regions analysed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global pharmaceutical CDMO market, with a 43% market revenue share in 2023.
North America has a well-established pharmaceutical industry with both manufacturing capabilities and innovative environment. It is home to advanced infrastructure as well as access to state-of-the art technologies that drive research, development and innovation. Stringent regulatory framework offers conducive environment for innovation as well as ensures safety of the products. significant research and development infrastructure from both public and private players augments that market’s growth. similarly, collaborations and partnerships also drive innovation augmenting the market’s growth.
North America Region Pharmaceutical CDMO Market Share in 2023 - 43%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The product segment is divided into API and drug product. The API segment dominated the market, with a market share of around 56% in 2023. API stands for Active Pharmaceutical Ingredients (APIs. They are the fundamental components of any drug. They are responsible for the therapeutic effects and the overall efficacy of the drugs. The fundamental role of API in pharmaceuticals requires efficient, reliable and scalable manufacturing capabilities that are offered by CDMOs. Therefore, CDMOs are critical for API development and manufacturing.
The workflow segment is divided into clinical and commercial. The commercial segment dominated the market, with a market share of around 58% in 2023. Commercial Workflow is commercial or large-scale production and manufacturing. It is used to mass produce already developed and tested drugs for marketing. CDMOs are ideal for commercial workflow as they have the necessary infrastructure, specialization and expertise. Commercial workflow has a reduced risk of data and knowledge theft. CDMOs offer efficient, safe, and quality manufacturing which is compliant with regulatory framework of the market as well.
The application segment is divided into oncology, infectious diseases and neurological disorders. The oncology segment dominated the market, with a market share of around 38% in 2023. Oncology deals with every aspect related to cancer, its diagnosis and treatment. cancer does not have a cure and it affects millions globally making it a market with untapped and unmet potential. There has been significant research and development to diagnose and treat cancers. CDMOs are critical in Oncology research with their specialization, technology and expertise.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2023 | USD 150 Billion |
Market size value in 2033 | USD 295.07 Billion |
CAGR (2024 to 2033) | 7% |
Historical data | 2020-2022 |
Base Year | 2023 |
Forecast | 2024-2033 |
Region | The regions analysed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analysed at the country level. |
Segments | Product, Workflow and Application |
As per The Brainy Insights, the size of the global pharmaceutical CDMO market was valued at USD 150 billion in 2023 to USD 295.07 billion by 2033.
Global pharmaceutical CDMO market is growing at a CAGR of 7% during the forecast period 2024-2033.
The market's growth will be influenced by the globalization of pharmaceuticals.
Confidentiality concerns could hamper the market growth.
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global pharmaceutical CDMO market based on below mentioned segments:
Global Pharmaceutical CDMO Market by Product:
Global Pharmaceutical CDMO Market by Workflow:
Global Pharmaceutical CDMO Market by Application:
Global Pharmaceutical CDMO Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date